Compare Nvidia Corp (NVDA) vs Health Care Select Sector SPDR Fund (XLV) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Nvidia Corp vs Health Care Select Sector SPDR Fund — how do they compare? Nvidia Corp trades at $234.16 (market cap $5.57T), while Health Care Select Sector SPDR Fund trades at $168.16 (market cap $43.48B). The key difference: Nvidia Corp is far larger — about 128.1× Health Care Select Sector SPDR Fund's market cap, and Nvidia Corp pays a 0.43% dividend while Health Care Select Sector SPDR Fund pays none. Which is the better fit depends on your goals — on Pluang, investors hold Nvidia Corp for 115 Days and Health Care Select Sector SPDR Fund for 100 Days on average.
| NVDA | XLV | |
|---|---|---|
Market Cap | $5.57T | $43.48B |
Volume | 117,720,595 | 11,121,431 |
Sector | Technology | — |
52-Week High | $239.27 | $175.68 |
52-Week Low | $165.17 | $141.95 |
Typical Hold Time | 115 Days | 100 Days |
Enterprise Value | $5.54T | — |
Dividend Yield | 0.43% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
NVIDIA (NVDA) trades at $237.36, down 0.8% on the day, amid strong fundamental performance with revenue surging to $130.5 billion in 2025 and net income reaching $72.88 billion. The stock maintains a bullish technical outlook with moving averages signaling strength, though RSI levels suggest potential overbought conditions. Recent earnings beats and a 75.95% analyst buy rating support positive sentiment, while the company's dominant position in AI chips drives continued growth expectations.
Outlook remains positive with a consensus price target of $339.17 representing significant upside potential. Key opportunities include sustained AI demand and expanding market leadership, while risks involve increased competition, peak AI spending concerns, and valuation metrics above industry averages. The stock's current valuation reflects high growth expectations that must be met to justify further appreciation.
XLV trades at $168.81, up 1.03% today, with a bullish technical signal driven by moving averages. The ETF holds 61 healthcare stocks from the S&P 500, offering broad sector exposure at a low 0.08% expense ratio. Recent news highlights its defensive appeal amid market volatility and potential Fed rate hikes, with articles comparing it favorably to peers like IBB and PJP on cost and diversification.
Outlook is positive given healthcare's defensive growth profile and XLV's cost efficiency, but risks include political uncertainty from midterm elections and sector-specific volatility from drug trial outcomes. Wall Street sentiment is constructive, with the ETF near key resistance at $170.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Nvidia Corp
NVIDIA Corporation designs, develops, and markets three dimensional (3D) graphics processors and related software. The Company offers products that provides interactive 3D graphics to the mainstream personal computer market.
Read more on NVDA →About Health Care Select Sector SPDR Fund
In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies from the following industries: pharmaceuticals; health care equipment & supplies; health care providers & services; biotechnology; life sciences tools & services; and health care technology. The fund is non-diversified.
Read more on XLV →
